For the Inventor, By the Inventor

Enter assignee name

Stealth Biotherapeutics Inc.

USPTO Granted Patents = 69

CIPO Patents = 5

EPO Patents = 16

Trademarks = 1

Forward Citations = 178

Loading Chart...

Loading Chart...

29 inventors (with patents filed for the assignee):

D Travis Wilson (41 out of 42 patents)

Scott M Duncan (16 out of 37 patents)

Mark J Bamberger (10 out of 11 patents)

4. Guozhu Zheng (8 out of 8 patents)

5. Robert A Kloner (6 out of 7 patents)

6. Martin P Redmon (6 out of 14 patents)

7. Dennis Keefe (5 out of 5 patents)

8. Liping Liu (4 out of 34 patents)

9. Shibo Tang (4 out of 6 patents)

10. Xiaoling Liang (4 out of 6 patents)

11. Marc W Andersen (3 out of 14 patents)

12. Inese Smukste (3 out of 3 patents)

13. Vania Broccoli (2 out of 2 patents)

14. Kenneth Borow (2 out of 2 patents)

15. Sharon Hale (2 out of 2 patents)

Core Competencies:

Mitochondria-Targeting Peptides

Aromatic-Cationic Peptides

Crystalline Salt Forms

Friedreich's Ataxia

Amyotrophic Lateral Sclerosis

Barth Syndrome

Pharmaceutically Relevant Peptides

Combination Therapies

69 patents: Sort by Forward Citations

1. 12404300 - Mitochondria-targeting peptides (2025-09-02),

2. 12337023 - Methods and compositions for the prevention and treatment of disease (2025-06-24),

3. 12297502 - Methods and compositions for detecting and diagnosing diseases and conditions (2025-05-13),

4. 12268724 - Methods and compositions for the prevention or treatment of Barth Syndrome (2025-04-08),

5. 12252554 - Analogs that target mitochondrial diseases (2025-03-18),

6. 12252553 - Crystalline salt forms (2025-03-18),

7. 12110345 - Crystalline salt forms of Boc-D-Arg-DMT-Lys-(Boc)-Phe-NH (2024-10-08),

8. 12065511 - Aromatic-cationic peptides and uses of same (2024-08-20),

9. 12049455 - Compositions and methods for the prevention and/or treatment of mitochondrial disease, including Friedreich's ataxia (2024-07-30),

10. 12037414 - Processes for preparing pharmaceutically relevant peptides (2024-07-16),

11. 12037350 - Compositions and methods for the prevention and/or treatment of mitochondrial disease, including Friedreich's ataxia (2024-07-16),

12. 12018094 - Crystalline dipeptides useful in the synthesis of elamipretide (2024-06-25),

13. 12016843 - Compositions and methods for the treatment of amyotrophic lateral sclerosis, parkinson's disease, parkinson's disease with dementia, dementia with lewy bodies, and multiple system atrophy (2024-06-25),

14. 11998585 - Methods and compositions for increasing the dose of a chemotherapeutic agent (2024-06-04),

15. 11944662 - Methods and compositions for preventing or treating ophthalmic conditions (2024-04-02),

Company Overview

Stealth Biotherapeutics Inc., headquartered in Monaco, specializes in the development of innovative mitochondrial therapeutics. The company focuses on creating mitochondria-targeting peptides and aromatic-cationic peptides, which are designed to address various mitochondrial dysfunction-related diseases. Their research encompasses conditions such as Friedreich's Ataxia, Amyotrophic Lateral Sclerosis, and Barth Syndrome, emphasizing the potential of pharmaceutically relevant peptides and combination therapies to improve patient outcomes.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

69 Patents

#1 in Monaco

#1 in Monaco

#10,761 in the World

Stealth Biotherapeutics Inc.

Forward Citations = 178

29 inventors:

D Travis Wilson (41 out of 42 patents)

Scott M Duncan (16 out of 37 patents)

Mark J Bamberger (10 out of 11 patents)

4. Guozhu Zheng (8 out of 8 patents)

5. Robert A Kloner (6 out of 7 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Stealth Biotherapeutics Inc.. Retrieved from https://idiyas.com/company/stealth-biotherapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…